nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—embryo—amyotrophic lateral sclerosis	0.0597	0.126	CbGeAlD
Amlexanox—FGF1—appendage—amyotrophic lateral sclerosis	0.0525	0.111	CbGeAlD
Amlexanox—PDE4C—tongue—amyotrophic lateral sclerosis	0.0442	0.0936	CbGeAlD
Amlexanox—FGF1—nerve—amyotrophic lateral sclerosis	0.0372	0.0789	CbGeAlD
Amlexanox—FGF1—hindbrain—amyotrophic lateral sclerosis	0.0279	0.0591	CbGeAlD
Amlexanox—PDE4C—brainstem—amyotrophic lateral sclerosis	0.0194	0.0411	CbGeAlD
Amlexanox—FGF1—embryo—amyotrophic lateral sclerosis	0.0174	0.0369	CbGeAlD
Amlexanox—FGF1—brainstem—amyotrophic lateral sclerosis	0.016	0.0339	CbGeAlD
Amlexanox—S100A13—nervous system—amyotrophic lateral sclerosis	0.0136	0.0288	CbGeAlD
Amlexanox—S100A13—central nervous system—amyotrophic lateral sclerosis	0.0131	0.0277	CbGeAlD
Amlexanox—S100A13—cerebellum—amyotrophic lateral sclerosis	0.0128	0.0271	CbGeAlD
Amlexanox—FGF1—medulla oblongata—amyotrophic lateral sclerosis	0.0111	0.0236	CbGeAlD
Amlexanox—S100A13—brain—amyotrophic lateral sclerosis	0.0104	0.022	CbGeAlD
Amlexanox—S100A12—brain—amyotrophic lateral sclerosis	0.0103	0.0217	CbGeAlD
Amlexanox—PDE4C—nervous system—amyotrophic lateral sclerosis	0.0102	0.0215	CbGeAlD
Amlexanox—FGF1—spinal cord—amyotrophic lateral sclerosis	0.00994	0.0211	CbGeAlD
Amlexanox—PDE4C—central nervous system—amyotrophic lateral sclerosis	0.00979	0.0207	CbGeAlD
Amlexanox—PDE4D—cerebellum—amyotrophic lateral sclerosis	0.00842	0.0178	CbGeAlD
Amlexanox—FGF1—nervous system—amyotrophic lateral sclerosis	0.00837	0.0177	CbGeAlD
Amlexanox—FGF1—central nervous system—amyotrophic lateral sclerosis	0.00806	0.0171	CbGeAlD
Amlexanox—FGF1—cerebellum—amyotrophic lateral sclerosis	0.00788	0.0167	CbGeAlD
Amlexanox—PDE4C—brain—amyotrophic lateral sclerosis	0.00777	0.0165	CbGeAlD
Amlexanox—PDE4A—cerebellum—amyotrophic lateral sclerosis	0.00745	0.0158	CbGeAlD
Amlexanox—PDE4D—brain—amyotrophic lateral sclerosis	0.00684	0.0145	CbGeAlD
Amlexanox—FGF1—brain—amyotrophic lateral sclerosis	0.0064	0.0136	CbGeAlD
Amlexanox—PDE4B—medulla oblongata—amyotrophic lateral sclerosis	0.00629	0.0133	CbGeAlD
Amlexanox—PDE4A—brain—amyotrophic lateral sclerosis	0.00605	0.0128	CbGeAlD
Amlexanox—PDE4B—spinal cord—amyotrophic lateral sclerosis	0.0056	0.0119	CbGeAlD
Amlexanox—PDE4B—nervous system—amyotrophic lateral sclerosis	0.00472	0.01	CbGeAlD
Amlexanox—PDE4B—central nervous system—amyotrophic lateral sclerosis	0.00455	0.00963	CbGeAlD
Amlexanox—PDE4B—cerebellum—amyotrophic lateral sclerosis	0.00444	0.00942	CbGeAlD
Amlexanox—PDE4B—brain—amyotrophic lateral sclerosis	0.00361	0.00765	CbGeAlD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.0021	0.00398	CbGpPWpGaD
Amlexanox—FGF1—GAB1 signalosome—ERBB4—amyotrophic lateral sclerosis	0.0021	0.00397	CbGpPWpGaD
Amlexanox—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—ERBB4—amyotrophic lateral sclerosis	0.00205	0.00388	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00204	0.00387	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—ATF1—amyotrophic lateral sclerosis	0.00198	0.00374	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00192	0.00364	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.00189	0.00358	CbGpPWpGaD
Amlexanox—S100A12—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00186	0.00352	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—CASP9—amyotrophic lateral sclerosis	0.00181	0.00343	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00178	0.00337	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00177	0.00336	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00175	0.00331	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—CASP9—amyotrophic lateral sclerosis	0.0017	0.00322	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—CASP9—amyotrophic lateral sclerosis	0.00169	0.00321	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—CASP9—amyotrophic lateral sclerosis	0.00168	0.00319	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—CASP9—amyotrophic lateral sclerosis	0.00168	0.00318	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—CASP9—amyotrophic lateral sclerosis	0.00165	0.00313	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—MMP9—amyotrophic lateral sclerosis	0.00162	0.00307	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.00162	0.00307	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—VEGFA—amyotrophic lateral sclerosis	0.0016	0.00303	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00158	0.00299	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—CASP9—amyotrophic lateral sclerosis	0.00158	0.00299	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—CASP9—amyotrophic lateral sclerosis	0.00158	0.00299	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—CASP9—amyotrophic lateral sclerosis	0.00158	0.00299	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—CASP9—amyotrophic lateral sclerosis	0.00156	0.00296	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—ERBB4—amyotrophic lateral sclerosis	0.00155	0.00293	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—CASP9—amyotrophic lateral sclerosis	0.00155	0.00293	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—CASP9—amyotrophic lateral sclerosis	0.00154	0.00292	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00153	0.0029	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00153	0.00289	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events triggered by IGF1R—IGF1—amyotrophic lateral sclerosis	0.0015	0.00283	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00148	0.00281	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00147	0.00278	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—ATF1—amyotrophic lateral sclerosis	0.00147	0.00278	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.00146	0.00276	CbGpPWpGaD
Amlexanox—FGF1—IGF1R signaling cascade—IGF1—amyotrophic lateral sclerosis	0.00146	0.00276	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—ERBB4—amyotrophic lateral sclerosis	0.00146	0.00276	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—ERBB4—amyotrophic lateral sclerosis	0.00145	0.00274	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—ERBB4—amyotrophic lateral sclerosis	0.00144	0.00273	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—ERBB4—amyotrophic lateral sclerosis	0.00144	0.00272	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.00141	0.00268	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	0.00141	0.00267	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—CASP9—amyotrophic lateral sclerosis	0.0014	0.00265	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00139	0.00263	CbGpPWpGaD
Amlexanox—IL3—Immune System—DCTN1—amyotrophic lateral sclerosis	0.00137	0.00259	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00136	0.00258	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.00135	0.00256	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—ERBB4—amyotrophic lateral sclerosis	0.00135	0.00256	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—ERBB4—amyotrophic lateral sclerosis	0.00135	0.00256	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—ERBB4—amyotrophic lateral sclerosis	0.00134	0.00253	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00133	0.00253	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—ERBB4—amyotrophic lateral sclerosis	0.00133	0.00251	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—ERBB4—amyotrophic lateral sclerosis	0.00132	0.0025	CbGpPWpGaD
Amlexanox—FGF1—Disease—TPK1—amyotrophic lateral sclerosis	0.00129	0.00245	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00125	0.00237	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.00125	0.00237	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.0012	0.00228	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.0012	0.00227	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—ERBB4—amyotrophic lateral sclerosis	0.0012	0.00226	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00119	0.00226	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00116	0.00219	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.00113	0.00214	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.00113	0.00213	CbGpPWpGaD
Amlexanox—S100A12—Immune System—DCTN1—amyotrophic lateral sclerosis	0.00109	0.00207	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00108	0.00205	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.00107	0.00203	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.00107	0.00203	CbGpPWpGaD
Amlexanox—FGF1—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.00106	0.00201	CbGpPWpGaD
Amlexanox—FGF1—Disease—VTA1—amyotrophic lateral sclerosis	0.00103	0.00196	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.00103	0.00195	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.00103	0.00195	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00102	0.00193	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000981	0.00186	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000966	0.00183	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000935	0.00177	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.00092	0.00174	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000918	0.00174	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000891	0.00169	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000875	0.00166	CbGpPWpGaD
Amlexanox—IL3—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000873	0.00165	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000854	0.00162	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00083	0.00157	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000821	0.00155	CbGpPWpGaD
Amlexanox—IL3—Immune System—ATF1—amyotrophic lateral sclerosis	0.000818	0.00155	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000813	0.00154	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000813	0.00154	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000812	0.00154	CbGpPWpGaD
Amlexanox—FGF1—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000784	0.00148	CbGpPWpGaD
Amlexanox—IL3—Immune System—CASP9—amyotrophic lateral sclerosis	0.000779	0.00148	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000775	0.00147	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000763	0.00144	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	0.000753	0.00143	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000752	0.00142	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000738	0.0014	CbGpPWpGaD
Amlexanox—FGF1—Disease—PLB1—amyotrophic lateral sclerosis	0.000709	0.00134	CbGpPWpGaD
Amlexanox—S100A12—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000699	0.00132	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000694	0.00131	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000686	0.0013	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000683	0.00129	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000673	0.00128	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000668	0.00127	CbGpPWpGaD
Amlexanox—IL3—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000667	0.00126	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ATF1—amyotrophic lateral sclerosis	0.000656	0.00124	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000653	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000644	0.00122	CbGpPWpGaD
Amlexanox—FGF1—Disease—VCP—amyotrophic lateral sclerosis	0.000632	0.0012	CbGpPWpGaD
Amlexanox—IL3—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000627	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000626	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000625	0.00118	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CASP9—amyotrophic lateral sclerosis	0.000625	0.00118	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000619	0.00117	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000613	0.00116	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000607	0.00115	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000604	0.00114	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000599	0.00113	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000589	0.00111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000575	0.00109	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000568	0.00108	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000564	0.00107	CbGpPWpGaD
Amlexanox—IL3—Immune System—C3—amyotrophic lateral sclerosis	0.000554	0.00105	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000541	0.00102	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000539	0.00102	CbGpPWpGaD
Amlexanox—S100A12—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000535	0.00101	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000532	0.00101	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000532	0.00101	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000531	0.00101	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00053	0.001	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000529	0.001	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000526	0.000996	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000525	0.000993	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000522	0.000988	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000513	0.000971	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000504	0.000954	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000504	0.000954	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000503	0.000952	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.0005	0.000948	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000496	0.00094	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000496	0.00094	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000474	0.000898	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.000474	0.000897	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000467	0.000884	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000463	0.000877	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000459	0.00087	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000458	0.000867	CbGpPWpGaD
Amlexanox—FGF1—Disease—CST3—amyotrophic lateral sclerosis	0.000453	0.000858	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000453	0.000857	CbGpPWpGaD
Amlexanox—S100A12—Immune System—C3—amyotrophic lateral sclerosis	0.000444	0.000841	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000442	0.000838	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000441	0.000835	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00044	0.000833	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000436	0.000825	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000436	0.000825	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000431	0.000817	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000428	0.000811	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000428	0.000811	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000419	0.000793	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000408	0.000772	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000406	0.000768	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000403	0.000764	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000401	0.00076	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000401	0.000759	CbGpPWpGaD
Amlexanox—FGF1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.0004	0.000757	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000389	0.000736	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000383	0.000725	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00038	0.00072	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000376	0.000712	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ATF1—amyotrophic lateral sclerosis	0.000375	0.00071	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000373	0.000706	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000364	0.00069	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000361	0.000684	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000358	0.000679	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000357	0.000676	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000355	0.000672	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000339	0.000642	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000338	0.000641	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000337	0.000639	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000334	0.000632	CbGpPWpGaD
Amlexanox—FGF1—Disease—CASP9—amyotrophic lateral sclerosis	0.00033	0.000624	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000328	0.000621	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000323	0.000611	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000322	0.00061	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000315	0.000596	CbGpPWpGaD
Amlexanox—FGF1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000306	0.000579	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000299	0.000567	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000298	0.000564	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000295	0.000559	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000287	0.000544	CbGpPWpGaD
Amlexanox—FGF1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000282	0.000534	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000281	0.000532	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000281	0.000532	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000277	0.000525	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000276	0.000523	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000276	0.000522	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000268	0.000507	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00026	0.000492	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00026	0.000492	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000258	0.000489	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C3—amyotrophic lateral sclerosis	0.000254	0.000481	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000248	0.000469	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000242	0.000459	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000241	0.000456	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000231	0.000437	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00023	0.000435	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000229	0.000434	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000226	0.000428	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOE—amyotrophic lateral sclerosis	0.000218	0.000413	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000215	0.000408	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000214	0.000405	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000212	0.000402	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000212	0.000401	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000201	0.00038	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.0002	0.000379	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000199	0.000377	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000198	0.000374	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00019	0.00036	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000186	0.000352	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000186	0.000352	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.00018	0.000341	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000177	0.000335	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000177	0.000335	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000176	0.000333	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000164	0.000311	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000164	0.00031	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000154	0.000291	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000153	0.000289	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—amyotrophic lateral sclerosis	0.00015	0.000283	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000146	0.000277	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000136	0.000258	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000136	0.000257	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000135	0.000256	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000128	0.000243	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000126	0.000239	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000118	0.000224	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000115	0.000218	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000113	0.000213	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000112	0.000212	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000106	0.000202	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000104	0.000197	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.0001	0.00019	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.85e-05	0.000187	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.72e-05	0.000184	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.56e-05	0.000181	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.19e-05	0.000174	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.85e-05	0.000168	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.72e-05	0.000165	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.25e-05	0.000156	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.59e-05	0.000144	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.22e-05	0.000137	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.68e-05	0.000127	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.23e-05	0.000118	CbGpPWpGaD
